Connect Biopharma HldgsCNTB
13F holders, Q4 2025 (December 31)1holders
0new positions
0sold out
$2.82avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Connect Biopharma Hldgs Ltd. (CNTB) in their 13F filings, unchanged from Q3 2025. 0 opened new positions and 0 sold out. The largest holder was EverSource Wealth Advisors, LLC ($4K).
- Company
- Connect Biopharma Hldgs Ltd.
- CUSIP
- 207523101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 294 shares sold, net −294 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| EverSource Wealth Advisors, LLC | 0.00% | Reduce -18.6% | 1,288 | $4K |
"% of holder's portfolio" is CNTB's weight in each manager's 13F, not the share of Connect Biopharma Hldgs Ltd. the manager owns.